Montag & Caldwell’s ResMed RMD Stock Holding History

Montag & Caldwell’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-8,184	Closed	-$587K	–	110
2015 Q1	$587K	Sell	8,184 -2,586	-24%	-$168K	0.01%	83
2014 Q4	$604K	Sell	10,770 -870	-7%	-$45.4K	0.01%	82
2014 Q3	$574K	Sell	11,640 -5,735	-33%	-$292K	0.01%	78
2014 Q2	$880K	Sell	17,375 -90	-0.5%	-$4.46K	0.01%	76
2014 Q1	$781K	Sell	17,465 -6,800	-28%	-$305K	0.01%	83
2013 Q4	$1.14M	Sell	24,265 -8,785	-27%	-$445K	0.01%	61
2013 Q3	$1.75M	Buy	33,050 +3,610	+12%	+$175K	0.01%	44
2013 Q2	$1.33M	Buy	+29,440	New	+$1.4M	0.01%	42

Other funds holding RMD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Montag & Caldwell's RMD Position: Q2 2015 in Review

Montag & Caldwell sold out of ResMed (RMD) in Q2 2015, closing a stake of 8,184 shares — an estimated $587K sold.

Montag & Caldwell first reported a position in RMD in Q2 2013 and held it in 8 quarters. The position peaked at $1.75M in Q3 2013. 312 funds tracked by Wall St. Rank hold RMD as of Q2 2015.

Montag & Caldwell reported no remaining ResMed position as of Q2 2015 after selling out during the quarter.
Montag & Caldwell sold 8,184 ResMed shares in Q2 2015, an estimated $587K.
Montag & Caldwell first reported a position in ResMed in Q2 2013 and held it in 8 quarters.
Montag & Caldwell's ResMed position peaked at $1.75M in Q3 2013.
312 funds tracked by Wall St. Rank held ResMed as of Q2 2015.

Based on Montag & Caldwell's 13F filing for Q2 2015, filed 27 Jul 2015.